BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32170099)

  • 1. Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice.
    Della-Valle V; Roos-Weil D; Scourzic L; Mouly E; Aid Z; Darwiche W; Lecluse Y; Damm F; Mémet S; Mercher T; Aoufouchi S; Nguyen-Khac F; Bernard OA; Ghamlouch H
    Blood Cancer J; 2020 Mar; 10(3):38. PubMed ID: 32170099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.
    Mansouri L; Noerenberg D; Young E; Mylonas E; Abdulla M; Frick M; Asmar F; Ljungström V; Schneider M; Yoshida K; Skaftason A; Pandzic T; Gonzalez B; Tasidou A; Waldhueter N; Rivas-Delgado A; Angelopoulou M; Ziepert M; Arends CM; Couronné L; Lenze D; Baldus CD; Bastard C; Okosun J; Fitzgibbon J; Dörken B; Drexler HG; Roos-Weil D; Schmitt CA; Munch-Petersen HD; Zenz T; Hansmann ML; Strefford JC; Enblad G; Bernard OA; Ralfkiaer E; Erlanson M; Korkolopoulou P; Hultdin M; Papadaki T; Grønbæk K; Lopez-Guillermo A; Ogawa S; Küppers R; Stamatopoulos K; Stavroyianni N; Kanellis G; Rosenwald A; Campo E; Amini RM; Ott G; Vassilakopoulos TP; Hummel M; Rosenquist R; Damm F
    Blood; 2016 Dec; 128(23):2666-2670. PubMed ID: 27670424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.
    Mansouri L; Sutton LA; Ljungström V; Bondza S; Arngården L; Bhoi S; Larsson J; Cortese D; Kalushkova A; Plevova K; Young E; Gunnarsson R; Falk-Sörqvist E; Lönn P; Muggen AF; Yan XJ; Sander B; Enblad G; Smedby KE; Juliusson G; Belessi C; Rung J; Chiorazzi N; Strefford JC; Langerak AW; Pospisilova S; Davi F; Hellström M; Jernberg-Wiklund H; Ghia P; Söderberg O; Stamatopoulos K; Nilsson M; Rosenquist R
    J Exp Med; 2015 Jun; 212(6):833-43. PubMed ID: 25987724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IκBε deficiency accelerates disease development in chronic lymphocytic leukemia.
    Bordini J; Lenzi C; Frenquelli M; Morabito A; Pseftogas A; Belloni D; Mansouri L; Tsiolas G; Perotta E; Ranghetti P; Gandini F; Genova F; Hägerstrand D; Gavriilidis G; Keisaris S; Pechlivanis N; Davi F; Kay NE; Langerak AW; Pospisilova S; Scarfò L; Makris A; Psomopoulos FE; Stamatopoulos K; Rosenquist R; Campanella A; Ghia P
    Leukemia; 2024 Apr; ():. PubMed ID: 38575671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFKBIE mutations are selected by the tumor microenvironment and contribute to immune escape in chronic lymphocytic leukemia.
    Bonato A; Chakraborty S; Bomben R; Canarutto G; Felician G; Martines C; Zucchetto A; Pozzo F; Vujovikj M; Polesel J; Chiarenza A; Del Principe MI; Del Poeta G; D'Arena G; Marasca R; Tafuri A; Laurenti L; Piazza S; Dimovski AJ; Gattei V; Efremov DG
    Leukemia; 2024 Mar; ():. PubMed ID: 38486128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions.
    Mansouri L; Papakonstantinou N; Ntoufa S; Stamatopoulos K; Rosenquist R
    Semin Cancer Biol; 2016 Aug; 39():40-8. PubMed ID: 27491692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired NFKBIE gene function decreases cellular uptake of methotrexate by down-regulating SLC19A1 expression in a human rheumatoid arthritis cell line.
    Imamura H; Yoshina S; Ikari K; Miyazawa K; Momohara S; Mitani S
    Mod Rheumatol; 2016 Jul; 26(4):507-16. PubMed ID: 26587663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined deficiency in IkappaBalpha and IkappaBepsilon reveals a critical window of NF-kappaB activity in natural killer cell differentiation.
    Samson SI; Mémet S; Vosshenrich CA; Colucci F; Richard O; Ndiaye D; Israël A; Di Santo JP
    Blood; 2004 Jun; 103(12):4573-80. PubMed ID: 14764534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reductions in I kappa B epsilon and changes in NF-kappa B activity during B lymphocyte differentiation.
    Doerre S; Mesires KP; Daley KM; McCarty T; Knoetig S; Corley RB
    J Immunol; 2005 Jan; 174(2):983-91. PubMed ID: 15634922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBI2 overexpression in mice leads to B1 B-cell expansion and chronic lymphocytic leukemia-like B-cell malignancies.
    Niss Arfelt K; Barington L; Benned-Jensen T; Kubale V; Kovalchuk AL; Daugvilaite V; Christensen JP; Thomsen AR; Egerod KL; Bassi MR; Spiess K; Schwartz TW; Wang H; Morse HC; Holst PJ; Rosenkilde MM
    Blood; 2017 Feb; 129(7):866-878. PubMed ID: 28003273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity.
    Tergaonkar V; Correa RG; Ikawa M; Verma IM
    Nat Cell Biol; 2005 Sep; 7(9):921-3. PubMed ID: 16136188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the pathogenesis of chronic lymphocytic leukemia.
    Klein U; Dalla-Favera R
    Semin Cancer Biol; 2010 Dec; 20(6):377-83. PubMed ID: 21029776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling.
    Hahn M; Bürckert JP; Luttenberger CA; Klebow S; Hess M; Al-Maarri M; Vogt M; Reißig S; Hallek M; Wienecke-Baldacchino A; Buch T; Muller CP; Pallasch CP; Wunderlich FT; Waisman A; Hövelmeyer N
    Leukemia; 2018 Jan; 32(1):72-82. PubMed ID: 28566736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the nuclear import and export functions of Ikappa B(epsilon).
    Lee SH; Hannink M
    J Biol Chem; 2002 Jun; 277(26):23358-66. PubMed ID: 11970947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premalignant cell dynamics in indolent B-cell malignancies.
    Milpied P; Nadel B; Roulland S
    Curr Opin Hematol; 2015 Jul; 22(4):388-96. PubMed ID: 26049761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of tumor necrosis factor-alpha and CD40L on NF-kappa B inhibitory proteins I kappa B alpha, beta and epsilon and on the induction of the Jun amino-terminal kinase pathway in Ramos Burkitt lymphoma cells.
    Laskov R; Berger N; Horwitz MS
    Eur Cytokine Netw; 2005 Dec; 16(4):267-76. PubMed ID: 16464740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and functional characterization of mouse IkappaBepsilon.
    Simeonidis S; Liang S; Chen G; Thanos D
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14372-7. PubMed ID: 9405619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Variation in NFKBIE Is Associated With Increased Risk of Pneumococcal Meningitis in Children.
    Lundbo LF; Harboe ZB; Clausen LN; Hollegaard MV; Sørensen HT; Hougaard DM; Konradsen HB; Nørgaard M; Benfield T
    EBioMedicine; 2016 Jan; 3():93-99. PubMed ID: 26870821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α.
    Pontoriero M; Fiume G; Vecchio E; de Laurentiis A; Albano F; Iaccino E; Mimmi S; Pisano A; Agosti V; Giovannone E; Altobelli A; Caiazza C; Mallardo M; Scala G; Quinto I
    J Mol Med (Berl); 2019 May; 97(5):675-690. PubMed ID: 30887112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.